Recent advances of the Ephrin and Eph family in cardiovascular development and pathologies
Article in iScience (July 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Current Progress on Central Cholinergic Receptors as Therapeutic Targets for Alzheimer's Disease
Article in Current Alzheimer Research (January 2024)
Integration of cancer-related genetic landscape of Eph receptors and ephrins with proteomics identifies a crosstalk between EPHB6 and EGFR
Article in Cell Reports (June 2023)